Overexpression of PSAT1 Gene Is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients With IDH1 Mutations and Chromosome 1p19q Codeletion

Cancers - Switzerland
doi 10.3390/cancers12010013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

PDCD5 Expression Predicts a Favorable Outcome in Patients With Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2013English

High Expression of SLC34A2 Is a Favorable Prognostic Marker in Lung Adenocarcinoma Patients

Tumor Biology
MedicineCancer Research
2017English

Isocitrate Dehydrogenase 1 (IDH1) Mutation-Specific microRNA Signature Predicts Favorable Prognosis in Glioblastoma Patients With IDH1 Wild Type

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2013English

VISTA Expression Is Associated With a Favorable Prognosis in Patients With High-Grade Serous Ovarian Cancer

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

High Expression of miR-25 Predicts Favorable Chemotherapy Outcome in Patients With Acute Myeloid Leukemia

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Copy Number Gain of MYCN Gene Is a Recurrent Genetic Aberration and Favorable Prognostic Factor in Chinese Pediatric Neuroblastoma Patients

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2013English

A 4-Gene Signature Associated With Clinical Outcome in High-Grade Gliomas

Clinical Cancer Research
Cancer ResearchOncology
2011English

Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis

Frontiers in Physiology
Physiology
2018English

Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas

Cancer Informatics
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy